Deepak Bhamidipati

521 total citations
23 papers, 307 citations indexed

About

Deepak Bhamidipati is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, Deepak Bhamidipati has authored 23 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 8 papers in Genetics. Recurrent topics in Deepak Bhamidipati's work include Glioma Diagnosis and Treatment (8 papers), Brain Metastases and Treatment (6 papers) and Genetic factors in colorectal cancer (4 papers). Deepak Bhamidipati is often cited by papers focused on Glioma Diagnosis and Treatment (8 papers), Brain Metastases and Treatment (6 papers) and Genetic factors in colorectal cancer (4 papers). Deepak Bhamidipati collaborates with scholars based in United States, China and Singapore. Deepak Bhamidipati's co-authors include Natalie Y.L. Ngoi, Timothy A. Yap, Vivek Subbiah, Joshua D. Palmer, Wenyin Shi, Maria Werner‐Wasik, Michael R. Sperling, Lyndon Kim, David J. Whellan and Jon Glass and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Deepak Bhamidipati

19 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deepak Bhamidipati United States 11 131 109 104 79 47 23 307
Jörn Rüssel Germany 8 142 1.1× 46 0.4× 123 1.2× 49 0.6× 44 0.9× 21 317
Kouki Inai Japan 8 75 0.6× 47 0.4× 211 2.0× 27 0.3× 57 1.2× 20 359
Caressa Hui United States 10 135 1.0× 78 0.7× 88 0.8× 27 0.3× 17 0.4× 47 344
Tomoyuki Igarashi Japan 12 150 1.1× 20 0.2× 152 1.5× 69 0.9× 30 0.6× 39 363
Daniele Scartoni Italy 9 76 0.6× 48 0.4× 212 2.0× 44 0.6× 44 0.9× 45 351
Catherine R. García United States 10 85 0.6× 139 1.3× 106 1.0× 59 0.7× 33 0.7× 23 327
Ginette Schiby Israel 7 90 0.7× 55 0.5× 87 0.8× 62 0.8× 14 0.3× 12 282
Cosette D. Champion United States 8 117 0.9× 91 0.8× 107 1.0× 29 0.4× 48 1.0× 10 264
A Goßmann Germany 9 100 0.8× 31 0.3× 145 1.4× 36 0.5× 15 0.3× 25 337

Countries citing papers authored by Deepak Bhamidipati

Since Specialization
Citations

This map shows the geographic impact of Deepak Bhamidipati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deepak Bhamidipati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deepak Bhamidipati more than expected).

Fields of papers citing papers by Deepak Bhamidipati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deepak Bhamidipati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deepak Bhamidipati. The network helps show where Deepak Bhamidipati may publish in the future.

Co-authorship network of co-authors of Deepak Bhamidipati

This figure shows the co-authorship network connecting the top 25 collaborators of Deepak Bhamidipati. A scholar is included among the top collaborators of Deepak Bhamidipati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deepak Bhamidipati. Deepak Bhamidipati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qiao, Wei, Keyur Patel, Deepak Bhamidipati, et al.. (2025). Long-Term Efficacy of Pembrolizumab and the Clinical Utility of ctDNA in Locally Advanced dMMR/MSI-H Solid Tumors. Nature Communications. 16(1). 4514–4514. 1 indexed citations
2.
Qiao, Wei, F. Anthony San Lucas, Keyur Patel, et al.. (2025). Prognostic value of circulating tumor DNA for progression-free survival in patients with locally advanced dMMR/MSI-H colorectal cancer managed without surgery.. Journal of Clinical Oncology. 43(4_suppl). 256–256. 1 indexed citations
3.
Lee, Choong‐kun, Taek Chung, Deepak Bhamidipati, et al.. (2025). Impact of HER2-positivity on prognosis and targeted therapeutic outcomes in advanced biliary tract cancer.. Journal of Clinical Oncology. 43(4_suppl). 629–629. 1 indexed citations
4.
Bhamidipati, Deepak, Ecaterina E. Dumbrava, Siqing Fu, et al.. (2024). Clinical characterization and therapeutic outcomes of patients (pts) with colorectal cancer (CRC) harboring somatic BRCA1/2 mutations.. Journal of Clinical Oncology. 42(3_suppl). 134–134.
5.
Bhamidipati, Deepak, Funda Meric‐Bernstam, Shubham Pant, et al.. (2024). Characterizing outcomes of ERBB2-amplified biliary tract cancer.. Journal of Clinical Oncology. 42(3_suppl). 492–492.
6.
Bhamidipati, Deepak, et al.. (2023). PARP inhibitors: enhancing efficacy through rational combinations. British Journal of Cancer. 129(6). 904–916. 86 indexed citations
7.
Konishi, Tsuyoshi, Harmeet Kaur, Y. Nancy You, et al.. (2023). Immunotherapy for localized MSI-H colorectal cancer: Characterizing endoscopic and imaging response.. Journal of Clinical Oncology. 41(16_suppl). 3610–3610. 1 indexed citations
8.
Bhamidipati, Deepak & Vivek Subbiah. (2023). Tumor-agnostic drug development in dMMR/MSI-H solid tumors. Trends in cancer. 9(10). 828–839. 24 indexed citations
9.
Bhamidipati, Deepak & Vivek Subbiah. (2022). Impact of tissue-agnostic approvals for patients with gastrointestinal malignancies. Trends in cancer. 9(3). 237–249. 13 indexed citations
10.
Bhamidipati, Deepak, Kanwal Raghav, Van K. Morris, et al.. (2022). Prognostic role of systemic inflammatory markers in patients with metastatic MSI-h/dMMR colorectal cancer receiving immunotherapy.. Journal of Clinical Oncology. 40(16_suppl). 3524–3524. 2 indexed citations
11.
Bhamidipati, Deepak, Hyunsoo Hwang, H. Wang, et al.. (2021). Metastatic small bowel adenocarcinoma: role of metastasectomy and systemic chemotherapy. ESMO Open. 6(3). 100132–100132. 10 indexed citations
12.
Bhamidipati, Deepak, Anuj Verma, Dawen Sui, et al.. (2021). An analysis of research biopsy core variability from over 5000 prospectively collected core samples. npj Precision Oncology. 5(1). 94–94. 7 indexed citations
13.
Palmer, Joshua D., Deepak Bhamidipati, Gaurav Shukla, et al.. (2020). Outcomes after stereotactic radiosurgery for CNS lymphoma. Journal of Neuro-Oncology. 147(2). 465–476. 8 indexed citations
14.
Palmer, Joshua D., Deepak Bhamidipati, Andrew Song, et al.. (2018). Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?. Journal of Neuro-Oncology. 140(3). 623–628. 31 indexed citations
15.
Blomain, Erik, et al.. (2018). Stereotactic radiosurgery practice patterns for brain metastases in the United States: a national survey. Journal of Radiation Oncology. 7(3). 241–246. 17 indexed citations
16.
Palmer, Joshua D., Deepak Bhamidipati, Minesh P. Mehta, et al.. (2018). Treatment recommendations for elderly patients with newly diagnosed glioblastoma lack worldwide consensus. Journal of Neuro-Oncology. 140(2). 421–426. 19 indexed citations
17.
18.
Shi, Wenyin, Erik Blomain, Joshua Siglin, et al.. (2017). Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment. Journal of Neuro-Oncology. 137(1). 171–177. 11 indexed citations
19.
Barney, C., Gaurav Shukla, Deepak Bhamidipati, & Joshua D. Palmer. (2017). Re-irradiation for recurrent glioblastoma multiforme. Chinese Clinical Oncology. 6(4). 36–36. 13 indexed citations
20.
Bhamidipati, Deepak, et al.. (2016). Cognitive Outcomes After Coronary Artery Bypass Grafting. Journal of Cardiothoracic and Vascular Anesthesia. 31(2). 707–718. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jörn Rüssel Breakdown of academic impact, for papers by Kouki Inai Breakdown of academic impact, for papers by Caressa Hui Breakdown of academic impact, for papers by Tomoyuki Igarashi Breakdown of academic impact, for papers by Daniele Scartoni Breakdown of academic impact, for papers by Catherine R. García Breakdown of academic impact, for papers by Ginette Schiby Breakdown of academic impact, for papers by Cosette D. Champion Breakdown of academic impact, for papers by A Goßmann
Rankless by CCL
2026